Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Cardiac tissue characterization and the diagnostic value of cardiovascular magnetic resonance in systemic connective tissue diseases.

Mavrogeni S, Sfikakis PP, Gialafos E, Bratis K, Karabela G, Stavropoulos E, Spiliotis G, Sfendouraki E, Panopoulos S, Bournia V, Kolovou G, Kitas GD.

Arthritis Care Res (Hoboken). 2014 Jan;66(1):104-12. doi: 10.1002/acr.22181.

2.

Cardiovascular magnetic resonance imaging in asymptomatic patients with connective tissue disease and recent onset left bundle branch block.

Mavrogeni S, Sfikakis PP, Karabela G, Stavropoulos E, Spiliotis G, Gialafos E, Panopoulos S, Bournia V, Manolopoulou D, Kolovou G, Kitas G.

Int J Cardiol. 2014 Jan 15;171(1):82-7. doi: 10.1016/j.ijcard.2013.11.059.

PMID:
24331867
3.

Cardiovascular magnetic resonance evaluation of paediatric patients with systemic lupus erythematosus and cardiac symptoms.

Mavrogeni S, Smerla R, Grigoriadou G, Servos G, Koutsogeorgopoulou L, Karabela G, Stavropoulos E, Spiliotis G, Kolovou G, Papadopoulos G.

Lupus. 2016 Mar;25(3):289-95. doi: 10.1177/0961203315611496.

PMID:
26453663
4.

Cardiovascular magnetic resonance imaging pattern at the time of diagnosis of treatment naïve patients with connective tissue diseases.

Mavrogeni S, Markousis-Mavrogenis G, Koutsogeorgopoulou L, Dimitroulas T, Bratis K, Kitas GD, Sfikakis P, Tektonidou M, Karabela G, Stavropoulos E, Katsifis G, Boki KA, Kitsiou A, Filaditaki V, Gialafos E, Plastiras S, Vartela V, Kolovou G.

Int J Cardiol. 2017 Feb 1. pii: S0167-5273(16)33153-9. doi: 10.1016/j.ijcard.2017.01.104. [Epub ahead of print]

PMID:
28185705
5.

Pathophysiology of Q waves in II, III, avF in systemic lupus erythematosus. Evaluation using cardiovascular magnetic resonance imaging.

Mavrogeni S, Bratis K, Kolovou G.

Lupus. 2012 Jul;21(8):821-9. doi: 10.1177/0961203312437437.

PMID:
22422802
6.

The diagnostic role of cardiac magnetic resonance imaging in detecting myocardial inflammation in systemic lupus erythematosus. Differentiation from viral myocarditis.

Mavrogeni S, Bratis K, Markussis V, Spargias C, Papadopoulou E, Papamentzelopoulos S, Constadoulakis P, Matsoukas E, Kyrou L, Kolovou G.

Lupus. 2013 Jan;22(1):34-43. doi: 10.1177/0961203312462265.

PMID:
23035042
7.

Cardiac involvement in ANCA (+) and ANCA (-) Churg-Strauss syndrome evaluated by cardiovascular magnetic resonance.

Mavrogeni S, Karabela G, Gialafos E, Stavropoulos E, Spiliotis G, Katsifis G, Kolovou G.

Inflamm Allergy Drug Targets. 2013 Oct;12(5):322-7.

PMID:
23909889
8.

Imaging Patterns of Cardiovascular Involvement in Mixed Connective Tissue Disease Evaluated by Cardiovascular Magnetic Resonance.

Mavrogeni S, Sfikakis PP, Dimitroulas T, Koutsogeorgopoulou L, Karabela G, Katsifis G, Stavropoulos E, Gialafos E, Spiliotis G, Kolovou G, Kitas GD.

Inflamm Allergy Drug Targets. 2015;14(2):111-6.

PMID:
26728774
9.

Myopericarditis, as the first sign of rheumatoid arthritis relapse, evaluated by cardiac magnetic resonance.

Mavrogeni S, Bratis K, Sfendouraki E, Papadopoulou E, Kolovou G.

Inflamm Allergy Drug Targets. 2013 Jun;12(3):206-11.

PMID:
23547732
10.

Cardiovascular Magnetic Resonance Imaging clarifies cardiac pathophysiology in early, asymptomatic diffuse systemic sclerosis.

Mavrogeni SI, Bratis K, Karabela G, Spiliotis G, Wijk Kv, Hautemann D, Reiber JH, Koutsogeorgopoulou L, Markousis-Mavrogenis G, Kolovou G, Stavropoulos E.

Inflamm Allergy Drug Targets. 2015;14(1):29-36.

PMID:
26374223
11.

Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification.

Ntusi NA, Piechnik SK, Francis JM, Ferreira VM, Rai AB, Matthews PM, Robson MD, Moon J, Wordsworth PB, Neubauer S, Karamitsos TD.

J Cardiovasc Magn Reson. 2014 Mar 4;16:21. doi: 10.1186/1532-429X-16-21.

12.

Edema and fibrosis imaging by cardiovascular magnetic resonance: how can the experience of Cardiology be best utilized in rheumatological practice?

Mavrogeni S, Sfikakis P, Dimitroulas T, Kolovou G, Kitas GD.

Semin Arthritis Rheum. 2014 Aug;44(1):76-85. doi: 10.1016/j.semarthrit.2014.01.005.

PMID:
24582213
13.

Myocarditis or "true" infarction by cardiac magnetic resonance in patients with a clinical diagnosis of myocardial infarction without obstructive coronary disease: A meta-analysis of individual patient data.

Tornvall P, Gerbaud E, Behaghel A, Chopard R, Collste O, Laraudogoitia E, Leurent G, Meneveau N, Montaudon M, Perez-David E, Sörensson P, Agewall S.

Atherosclerosis. 2015 Jul;241(1):87-91. doi: 10.1016/j.atherosclerosis.2015.04.816. Review.

PMID:
25967935
14.

Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis.

Lipinski MJ, McVey CM, Berger JS, Kramer CM, Salerno M.

J Am Coll Cardiol. 2013 Aug 27;62(9):826-38. doi: 10.1016/j.jacc.2013.03.080.

15.

Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease.

Steel K, Broderick R, Gandla V, Larose E, Resnic F, Jerosch-Herold M, Brown KA, Kwong RY.

Circulation. 2009 Oct 6;120(14):1390-400. doi: 10.1161/CIRCULATIONAHA.108.812503.

16.

Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents.

Ferreira VM, Piechnik SK, Dall'Armellina E, Karamitsos TD, Francis JM, Ntusi N, Holloway C, Choudhury RP, Kardos A, Robson MD, Friedrich MG, Neubauer S.

J Cardiovasc Magn Reson. 2014 May 23;16:36. doi: 10.1186/1532-429X-16-36.

17.

Functional and Morphological Parameters with Tissue Characterization of Cardiovascular Magnetic Imaging in Clinically Verified "Infarct-like Myocarditis".

Schwab J, Rogg HJ, Pauschinger M, Fessele K, Bareiter T, Bär I, Loose R.

Rofo. 2016 Apr;188(4):365-73. doi: 10.1055/s-0041-108200.

18.

Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging.

Klem I, Heitner JF, Shah DJ, Sketch MH Jr, Behar V, Weinsaft J, Cawley P, Parker M, Elliott M, Judd RM, Kim RJ.

J Am Coll Cardiol. 2006 Apr 18;47(8):1630-8.

19.

Cardiovascular magnetic resonance techniques and findings in children with myocarditis: a multicenter retrospective study.

Banka P, Robinson JD, Uppu SC, Harris MA, Hasbani K, Lai WW, Richmond ME, Fratz S, Jain S, Johnson TR, Maskatia SA, Lu JC, Samyn MM, Patton D, Powell AJ.

J Cardiovasc Magn Reson. 2015 Nov 17;17:96. doi: 10.1186/s12968-015-0201-6.

20.

Clinical applications of cardiac magnetic resonance imaging.

Pilz G, Heer T, Harrer E, Ali E, Hoefling B.

Minerva Cardioangiol. 2009 Jun;57(3):299-313. Review.

PMID:
19513011

Supplemental Content

Support Center